Gilead Sciences GILD
NASDAQ GILD
$168.08 +0.13 (+0.08%)
At close: Nov 13, 2026 · 4:00 PM EST

Gilead Sciences (GILD) Land & Improvements (2009 - 2011)

Updated

Analysis

Gilead Sciences (GILD) Land & Improvements (2009 - 2011) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Land & Improvements (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn -
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn -
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn -
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn -
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn -
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn -
10 Vertex Pharmaceuticals 136.55 Bn 104.28 Bn 2.91 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2011 149.38 Mn
Dec 31, 2010 137.81 Mn
Dec 31, 2009 137.81 Mn
API Access

Gilead Sciences Land & Improvements API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=land-and-improvements&ticker=GILD&period=max&api_key=YOUR_API_KEY